DICER1 and PRKRA in Colon Adenocarcinoma

Differential microRNA expression in colon adenocarcinoma (CA) was previously reported. MicroRNA biogenesis and function requires a set of proteins designated as the microRNA machinery, which includes DICER1 and PRKRA. Loss of heterozygosity at 14q32.13 DICER1 locus was detected in up to 60% of CA ca...

Full description

Bibliographic Details
Main Authors: S. Chiosea, M. Acquafondata, J. Luo, SF. Kuan, RR. Seethala
Format: Article
Language:English
Published: SAGE Publishing 2008-01-01
Series:Biomarker Insights
Online Access:https://doi.org/10.4137/BMI.S600
_version_ 1818553645630750720
author S. Chiosea
M. Acquafondata
J. Luo
SF. Kuan
RR. Seethala
author_facet S. Chiosea
M. Acquafondata
J. Luo
SF. Kuan
RR. Seethala
author_sort S. Chiosea
collection DOAJ
description Differential microRNA expression in colon adenocarcinoma (CA) was previously reported. MicroRNA biogenesis and function requires a set of proteins designated as the microRNA machinery, which includes DICER1 and PRKRA. Loss of heterozygosity at 14q32.13 DICER1 locus was detected in up to 60% of CA cases. The in silico gene array analysis of CA showed down-regulation of DICER1 and an up-regulation of PRKRA . Immunohistochemically, DICER1 expression was abnormal in 65% of CA (95 of 147 cases). PRKRA was deregulated in 70% of CA (32 of 46 cases). Expression of DICER1 and PRKRA was correlated with clinicopathologic features of CA. DICER1 up-regulation was seen more commonly in women. Only 10 of 46 cases immunostained for both DICER1 and PRKRA showed normal levels of both DICER1 and PRKRA. Microsatellite status of 32 cases was determined. Microsatellite instable cases showed DICER1 up-regulation more commonly when compared to microsatellite stable cases; however, this trend was not statistically significant. Abnormal DICER1 and/or PRKRA expression might explain the observed changes in microRNA profile. The status of the endogenous DICER1 and PRKRA in CA may help to predict the response to future RNA interference-based therapy.
first_indexed 2024-12-12T09:28:32Z
format Article
id doaj.art-c278b44b054245dcb7b36458c9140d7d
institution Directory Open Access Journal
issn 1177-2719
language English
last_indexed 2024-12-12T09:28:32Z
publishDate 2008-01-01
publisher SAGE Publishing
record_format Article
series Biomarker Insights
spelling doaj.art-c278b44b054245dcb7b36458c9140d7d2022-12-22T00:28:56ZengSAGE PublishingBiomarker Insights1177-27192008-01-01310.4137/BMI.S600DICER1 and PRKRA in Colon AdenocarcinomaS. Chiosea0M. Acquafondata1J. Luo2SF. Kuan3RR. Seethala4Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.Differential microRNA expression in colon adenocarcinoma (CA) was previously reported. MicroRNA biogenesis and function requires a set of proteins designated as the microRNA machinery, which includes DICER1 and PRKRA. Loss of heterozygosity at 14q32.13 DICER1 locus was detected in up to 60% of CA cases. The in silico gene array analysis of CA showed down-regulation of DICER1 and an up-regulation of PRKRA . Immunohistochemically, DICER1 expression was abnormal in 65% of CA (95 of 147 cases). PRKRA was deregulated in 70% of CA (32 of 46 cases). Expression of DICER1 and PRKRA was correlated with clinicopathologic features of CA. DICER1 up-regulation was seen more commonly in women. Only 10 of 46 cases immunostained for both DICER1 and PRKRA showed normal levels of both DICER1 and PRKRA. Microsatellite status of 32 cases was determined. Microsatellite instable cases showed DICER1 up-regulation more commonly when compared to microsatellite stable cases; however, this trend was not statistically significant. Abnormal DICER1 and/or PRKRA expression might explain the observed changes in microRNA profile. The status of the endogenous DICER1 and PRKRA in CA may help to predict the response to future RNA interference-based therapy.https://doi.org/10.4137/BMI.S600
spellingShingle S. Chiosea
M. Acquafondata
J. Luo
SF. Kuan
RR. Seethala
DICER1 and PRKRA in Colon Adenocarcinoma
Biomarker Insights
title DICER1 and PRKRA in Colon Adenocarcinoma
title_full DICER1 and PRKRA in Colon Adenocarcinoma
title_fullStr DICER1 and PRKRA in Colon Adenocarcinoma
title_full_unstemmed DICER1 and PRKRA in Colon Adenocarcinoma
title_short DICER1 and PRKRA in Colon Adenocarcinoma
title_sort dicer1 and prkra in colon adenocarcinoma
url https://doi.org/10.4137/BMI.S600
work_keys_str_mv AT schiosea dicer1andprkraincolonadenocarcinoma
AT macquafondata dicer1andprkraincolonadenocarcinoma
AT jluo dicer1andprkraincolonadenocarcinoma
AT sfkuan dicer1andprkraincolonadenocarcinoma
AT rrseethala dicer1andprkraincolonadenocarcinoma